CARVYKTI 100000000 1/1
ciltacabtagene autoleucel · INJECTION, SUSPENSION · Janssen Biotech, Inc.
CARVYKTI is a injection, suspension containing ciltacabtagene autoleucel at 100000000 1/1, taken intravenous. Manufactured by Janssen Biotech, Inc..
Key Facts
- Brand Name
- CARVYKTI
- Generic Name
- ciltacabtagene autoleucel
- NDC Code (Product)
57894-111- Manufacturer
- Janssen Biotech, Inc.
- Strength
- 100000000 1/1
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125746
- Marketing Start
- 02/28/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is CARVYKTI used for?
CARVYKTI contains ciltacabtagene autoleucel. It is a injection, suspension taken intravenous. Consult your doctor for specific uses.
Is CARVYKTI a controlled substance?
CARVYKTI is not classified as a controlled substance by the DEA.
What is the generic name for CARVYKTI?
The generic name for CARVYKTI is ciltacabtagene autoleucel. There are no other listed brand versions of ciltacabtagene autoleucel.
What is the NDC code for CARVYKTI 100000000 1/1?
The NDC (National Drug Code) for CARVYKTI 100000000 1/1 is 57894-111, listed by Janssen Biotech, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)